Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income margin | 21.2% | 21.6% | 17.4% | 21.1% | 22.1% | 22.4% | 18.5% | 20.0% | 18.5% | 20.7% | 17.8% | 16.7% | 17.2% | 15.4% | 18.7% | 20.3% | 51.0% | 17.7% | 20.9% | 28.1% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Operating Income margin is 28.8%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Operating Income margin for Novartis AG have been 21.6% over the past three years, and 21.9% over the past five years.
As of today, Novartis AG's Operating Income margin is 28.8%, which is higher than industry median of 20.3%. It indicates that Novartis AG's Operating Income margin is Good.